T h e hypothesis that uncoupling protein 3 (UCP3) is an uncoupling protein involved in heat dissipation is not unequivocally supported. An update of in vitro, ex vivo and in vivo studies testing this hypothesis is presented. Data are provided showing that exercise induces a fatty aciddependent increase in muscle UCP3 mRNA in humans. T h e proposed positive correlation between glycolytic capacity and UCP3 level in various muscle-fibre types in the mouse is reassessed. Finally, an association between an intronic polymorphism of UCP3 and adiposity is reported.
Introduction
In 1997, i.e. 21 years after the first report on uncoupling protein (UCP) 1, two novel members of the mitochondrial carrier family were discovered which displayed high ( 2 55 O b ) amino acid sequence identity to UCPl. Based on these identities the two novel proteins were considered as possible UCPs and named UCP2 and UCP3 [1, 2] . They were found to be highly expressed not only in rodents but also in humans; UCP2 in most tissues studied [ l ] and UCP3 mainly in skeletal muscle [2] . Since the discovery of UCP2 and UCP3 many experimental approaches have been developed to test the hypothesis that these proteins might be uncouplers of oxidative phosphorylation and, therefore, participate in heat dissipation. In this presentation we will focus on UCP3.
Data supporting or not the notion that UCP3 is thermogenic and thermoregulatory
In vitro experiments T h e function of UCPl as an uncoupler of oxidative phosphorylation and the specific inhibition of its activity by nucleotides are well documented [3] . Using heterologous yeast and mammalian cell expression systems, UCP3 was shown to decrease mitochondrial membrane potential, to increase whole-cell basal 0, consumption and to slightly 
In vivo experiments
In UCPl -knockout mice, adaptative cold-induced non-shivering and diet-induced thermogeneses were totally blunted, suggesting the absence of a UCPI-independent component (UCP2, UCP3) from these phenomena [8] . On the other hand, in rats on a high-fat diet, a correlation was observed between the resistance to the development of obesity and induction of skeletal-muscle UCP3
In two UCP3-knockout mice models generated recently no change in any of the energybalance parameters could be observed as compared with wild-type animals [10, 11] . In contrast with these results, transgenic mice overexpressing UCP3 mRNA more than 50-fold in their skeletal muscle were hyperphagic but weighed less than their wild-type controls [12] . Conditions that increase UCP3 expression, like fasting or triiodothyronine treatment, respectively did not change or decrease mitochondrial energy coupling in muscle, as assessed in vivo by "CC/"P-NMR [ 13,141.
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Ex vivo experiments
In mitochondria isolated from starved rat muscle that displayed a 2-fold increase in UCP3 protein, the proton conductance was similar to that of mitochondria from fed animals [15] . In contrast with this result, in mitochondria isolated from UCP3-knockout-mouse skeletal muscle, an overcoupling was observed characterized by a decreased State 4 respiration [lo] and a decreased proton leak [ l l ] , as compared with wild-type animals. In mitochondria isolated from trangenic mice overexpressing UCP3 in their skeletal muscle [ 121 an increased State 4 respiration accompanied by a decreased membrane potential was observed.
In conclusion, studies in vitro (transfected cells) and ex vivo (knockout and transgenic mice) suggest that UCP3 is thermogenic. In vivo studies show that UCP3 might be thermoregulatory only when dramatically overexpressed.
Mitochondria1 Uncoupling Proteins
Control of UCP3 activity in vivo
An interesting hypothesis is that the opening of the UCP3 ' channel ' would be allowed only in cells at rest. In cells with high metabolic rates, the UCP3 channel would be closed and inoperative [6] . Therefore, if UCP3 is functional only in cells with a low metabolic rate, the lack of UCP3 would not affect either diet-induced thermogenesis or exercise tolerance, as observed in knockout mice. On the other hand, constant overexpression of UCP3, as in transgenic mice, would strongly affect these parameters.
UCP3 and glucose utilization
An intriguing aspect of the biological role of UCP3 is its possible interaction with glucose uptake. A relationship between UCP3 expression and glucose uptake has been suggested in both rodents and humans. Indeed, in transgenic mice overexpressing UCP3 in their skeletal muscle, an increased insulin sensitivity was observed [12] . Furthermore, in L6 myotubes, UCP3 transfection was found to increase glucose transport. This phenomenon was mediated by activation of the phosphoinositide 3-kinase-dependent pathway [16] . Moreover, overexpression of G L U T 4 in mice caused an up-regulation of UCP3 in skeletal muscle [17] . In humans, the level of UCP3 mRNA in skeletal muscle of type I1 diabetic patients was lower than in control subjects [18] . There was also a positive correlation between UCP3 expression and whole-body insulin-mediated glucose utilization among diabetic patients [18] . These results suggest that glucose utilization or, in general, an overflow of substrate positively modulates UCP3 expression. They also suggest the opposite hypothesis, i.e. that UCP3 improves insulin sensitivity. If this were true then stimulation of UCP3 activity might help to correct insulin resistance.
A model of physical exercise in humans was used to investigate the effect of free fatty acids (FFA) and/or glucose oxidation on UCP3 mRNA level. This study was performed in collaboration with D r P. Schrauwen's group in the Department of Human Biology, Maastricht University, Maastricht, T h e Netherlands. Seven healthy untrained men exercised at 50°/o VoDmax for 2 h and then rested for 4 h. Skeletal-muscle biopsies and blood samples were taken before and 0, 1 and 4 h after exercise. To modulate plasma FFA levels, the experiment was performed twice, once after a fasting period and once with glucose ingestion. UCP3 mRNA was determined by competitive reverse transcriptase PCR. In the fasted state, plasma FFA levels increased during exercise whereas they were unchanged after glucose ingestion. Also, fat oxidation was higher after fasting. In the fasted state UCP3 mRNA expression was increased 4 h after exercise. This increase was prevented by glucose ingestion. In conclusion, our data suggest that the up-regulation of UCP3 mRNA following exercise is not a direct effect of exercise, but rather an effect of increased FFA availability/oxidation and that during exercise there is no correlation in skeletal muscle between glucose utilization and UCP3 expression.
UCP3 expression at the protein level Validation of the Western-blot technique
Many studies have been performed on the metabolic regulation of brown-adipose-tissue and skeletal-muscle UCP3 mRNA expression in both rodents and humans [4-61. Until now, very few of the numerous and often spectacular examples of UCP3 regulation observed in skeletal muscle at the mRNA level have been studied at the protein level. T h e reasons for this are the many difficulties encountered in getting specific antibodies and validation tests as well as good Western-blot conditions.
Since more and more studies erratically report Western-blot data it would be useful to update the UCP3 protein results presently available in the literature. T h e studies performed on UCP3-knockout mice or on transgenic mice overexpressing UCP3 in their skeletal muscle present convincing validations of the Western-blot techniques used. T h e Lilly anti-mouse UCP3 E4 antibody and the Chemicon anti-human UCP3 Cterminal antibody were found to react specifically with mouse UCP3, since the signal observed in wild-type animals was found to be abolished in UCP3-knockout-mouse muscle [10, 11] . T h e a-Diagnostic anti-human UCP3 C-terminal antibody was found to react specifically with mouse UCP3, as validated in a UCP3 transgenic-mouse model [12] . In the other studies, dedicated to the analyses of possible modulations of UCP3 at the protein level, either validated or non-validated antibodies were used.
In our laboratory, we used a new anti-human UCP3 C-terminal antibody (Research Diagnostics) and a Western-blot technique optimizing the protein transfer. We obtained a 34 kDa UCP3 signal that was validated using a UCP3-knockout-mouse model, adenovirus human UCP3-transfected cells and recombinant UCP3.
Distribution of UCP3 protein in various muscles
We first studied the distribution of UCP3 in the subsarcolemmal mitochondria obtained from different types of mouse muscle, i.e. tibialis anterior (TA), which is 2/3 fast oxidative glycolytic and 1 /3 fast glycolytic, gastrocnemius (Gn), which is 1/3 slow oxidative, 1/3 fast oxidative glycolytic and 1/3 fast glycolytic, and soleus (So), which is 90 O 0 slow oxidative. T h e UCP3 levels were found to differ considerably from one muscle type to the other. UCP3 protein level in G n was 2.5-fold and 2.8-fold higher than in T A and So, respectively. A determination of the amount of UCP3 mRNA performed by quantitative reverse transcriptase PCR in these same muscles, to allow a comparison between the respective UCP3 mRNA and protein levels, showed that the UCP3 mRNA levels were G n = T A > S o . T h e UCP3 mRNA level in G n was 2.1-fold higher than in So. Therefore the relative amounts of UCP3 protein and mRNA in the three muscles tested were comparable.
Hesselink et al. [19] , who studied the distribution of UCP3 protein in various human muscle types by immunofluorescence, showed a higher expression of UCP3 protein in glycolytic than in oxidative fibres of vastus lateralis muscle. In fact, in humans, fibres that have the lowest capacity to oxidize fatty acids express the highest level of UCP3. Our results show that these findings cannot be extended to rodent muscles. If indeed the UCP3 protein was more expressed in glycolytic than in oxidative muscles its density would to be highest in T A muscle, which is the most glycolytic of the three muscles tested.
UCP3 in intermyofibrillar mitochondria
T h e intermyofibrillar mitochondria should represent a biologically important population. Their preparation, using Nagarse protease, is not suitable for studies of UCP3 expression. Intermyofibrillar mitochondria UCP3 protein measurements are in progress in our laboratory.
UCP3 protein and fasting
Fasting was repeatedly shown to increase dramatically muscle UCP3 mRNA in rats and mice [4-61. Two studies reported that the increase in rat UCP3 protein induced by fasting was less than half the increase of UCP3 mRNA in experiments carried out in parallel [15, 20] . Our data confirmed these results which altogether indicated that, in fasting, the amplitude of UCP3 changes at the mRNA level are strongly damped down when the amount of protein is considered. This suggests a regulation of UCP3 expression at the translational level.
T h e phenomenon of the increase in UCP3 expression during fasting, called 'the fasting paradox', is therefore still observed, although at a lower level, when UCP3 protein instead of mRNA is measured.
UCP3 genetic studies
U p to now, the results of UCP3 genetic studies are rather controversial and only weak associations have been described between some UCP3 variants and obesity traits.
We have analysed, among 734 subjects from the Quebec Family Study (QFS), a new GA repeat microsatellite located in UCP3 gene intervening sequence 6 (GAIVS6). Covariance analysis across genotypes for different adiposity, resting energy expenditure and glucose metabolism variables was undertaken with age and sex, plus body fat and body mass for non-adiposity phenotypes, as covariates. We found strong associations between GAIVS6 and body-mass index, percentage of body fat, the sum of six skin-fold thickness and leptin level. Homozygotes for the GAIVS6 240 bp alleles (1 5 O O frequency in the QFS) showed higher adiposity than subjects with the GAIVS6 238 bp allele (7Ooo in QFS). These results suggest that some alleles of UCP3 might contribute to the aetiology of human obesity.
Altogether, the data presented support the view that UCP3 is thermogenic but the idea that it might be thermoregulatory is still controversial.
Introduction
T h e roles of uncoupling proteins 1-3 (UCPl-3) in human physiology can be directly tested using association studies, which examine the hypothesis that naturally occurring variants in the expressed genes, their promoters or introns, influence traits such as body-mass index (BMI) or energy expenditure. No studies have yet tested the possibility that variants of UCP4 and 5 (brain mitochondrial carrier protein, BMCPl) influence human physiology. Genetic studies in humans can provide definitive proof about the physiological function of a gene, such as the demonstration that people with mutations of the leptin gene are obese. However, mutations that cause obesity inherited in a simple Mendelian fashion (dominant or 
